Citation | Chen, C; Wilcoxen, KM; Huang, CQ; Xie, YF; McCarthy, JR; Webb, TR; Zhu, YF; Saunders, J; Liu, XJ; Chen, TK; Bozigian, H; Grigoriadis, DE Design of 2,5-dimethyl-3-(6-dimethyl-4-methylpyridin-3-yl)-7-dipropylaminopyrazolo[1,5-a]pyrimidine (NBI 30775/R121919) and structure--activity relationships of a series of potent and orally active corticotropin-releasing factor receptor antagonists. J Med Chem47:4787-98 (2004) [PubMed] Article |
---|
SMILES | CC(C)CCC(C)Nc1cc(C)nc2c(c(C)nn12)-c1cnc(cc1C)N(C)C |(8.29,4.19,;6.77,4.5,;6.3,5.97,;5.75,3.35,;4.25,3.68,;3.23,2.51,;1.71,2.82,;3.71,1.05,;2.68,-.1,;3.16,-1.55,;2.13,-2.71,;2.62,-4.16,;.64,-2.39,;.15,-.93,;-1.25,-.31,;-1.1,1.23,;-2.26,2.24,;.4,1.56,;1.17,.2,;-2.58,-1.08,;-2.58,-2.64,;-3.91,-3.41,;-5.24,-2.64,;-5.24,-1.1,;-3.91,-.31,;-3.92,1.23,;-6.58,-3.41,;-6.58,-4.95,;-7.93,-2.64,)| |